维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="HASANREISOGLU M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Effect of thick Tenons capsule on primary trabeculectomy with mitomycin-C 显示文摘	Akarsu C Onol M Hasanreisoglu B	2003	Acta Ophthamol Scand2003，81，：	1
2	Treatment modalities for Graves'ophthalmopathy:systematic review and meta analysis显示文摘	Stiebel-Kalish H Robenshtok E Hasanreisoglu M	2009	J Clin Endocrinol Metab2009，94，8：	1
3	Treatment modalities for Graves′ ophthalmopathy: systematic review and meta-analysis显示文摘	Stiebel-Kalish H Robenshtok E Hasanreisoglu M at al	2009	J Clin Endocrinol Metab2009，94，8：	1
4	Proinflammatory cytokines in a mouse model of central retinal artery occlusion 显示文摘	Kramer M Dadon S Hasanreisoglu M	2009	Mol Vis2009，15，：	1
5	Treatment modalities for Graves' ophthalmopathy:systematic review and meta- analysis显示文摘	Stiebel-Kalish H Robenshtok E Hasanreisoglu M	2009	J Clin Endocrinol Metab2009，94，：	1
6	Treat- ment modalities for Graves' ophthalmopathy: systematic review and metaanalysis 显示文摘	Stiebel-Kalish H Robenshtok E Hasanreisoglu M	2009	J Clin Endocrinol Metab2009，94，8：	1
7	Treatment modalities for Graves' ophthalmopathy:systematic review and metaanalysis显示文摘	STIEBEL KALISH H ROBENSHTOK E HASANREISOGLU M	2009	J Clin Endocrinol Metab2009，94，8：	1
8	Possible neuroprotective effect of brimonidine in a mouse model of ischaemic optic neuropathy 显示文摘	Goldenberg-Cohen N Dadon-Bar-E1 S Hasanreisoglu M	2009	Clin Experiment Ophthalmol2009，37，7：	1
9	Treatment modalities for Graves' ophthalmopathy:systematic review and meta analysis显示文摘	Stiebel-Kalish H Robenshtok E Hasanreisoglu M	2009	J Clin Endocrinol Metab2009，94，8：	1
10	Chorioretinectomy for perforating eye injuries显示文摘	Ozdek S Hasanreisoglu M Yuksel E	2013	Eye (Lond)2013，27，：	1
11	Effect of subconjuctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization 显示文摘	Dratviman-Storobinsky O Lubin B C Hasanreisoglu M	2009	Mol Vis2009，15，：	1
12	Intravitreal bevaeizumab as adjunct for neovacular glaueoma显示文摘	Hasanreisoglu M Weinberger D Mimouni K	2009	Eur J Oph thalmol2009，19，4：	1
13	Treatment modalities for graves' ophthalmopathy: systematic review and metaanalysis 显示文摘	STIEBEL - KALISH H ROBENSHTOK E HASANREISOGLU M	2009	The Journal of Clinical Endocrinology & Metabolism2009，94，8：	1
14	Treatment modalities for Graves' ophthalmopathy: systematic review and metananlysis显示文摘	Stiebel-Kalish H Robenshtok E Hasanreisoglu M	2009	Clin Endocrinol Metab2009，94，8：	1
15	Treatment modalities for Graves' ophthalmopathy:systematic review and Meta analysis显示文摘	Stiebel-Kalish H Robenshtok E Hasanreisoglu M		0，，：	1
16	Treatment modalities for Graves' phthalmopathy: systematic review and meta- analysis显示文摘	Stiebel-Kalish H Robenshtok E Hasanreisoglu M	2009	J Clin Endocrinol Metab2009，94，8：	1
17	Treatment modalities for Graves'ophthalmopathy:systematic review and metaanalysis显示文摘	Stiebel-Kalish H Robenshtok E Hasanreisoglu M	2009	J Clin Endocrinol Metab2009，94，8：	1
18	Postoperative 5 - fluomu- racil versus intraoperative mitomycin C in high -risk glaucoma filtering surgery: extended follow up 显示文摘	Akarsu C Onol M Hasanreisoglu B	2003	Clin Experiment Oph- thalmo12003，31，3：	1
19	Nonpenetrating glaucoma surgery: meta-analysis of recent results显示文摘	Hondur A Onol M Hasanreisoglu B	2008	J Glaucoma2008，17，：	1
20	Role of interleukin 8 in the pathogenesis of proliferative vitreoretinopathy 显示文摘	Aksunger A Or M Okur H Hasanreisoglu B Akbatur H	1997	Ophthalmogica1997，211，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示